Biochemical control of acromegaly in noncured patients is usually defined as serum growth hormone (GH) levels <2.0 µg/l, plus normal-for-age serum levels of insulin-like growth factor I (IGF-I).

As a disease considered rare, acromegaly is very uncommon ... the excess growth hormone produces severe alterations in other parts of the body: increased heart size, which can lead to heart ...

The FDA declined to approve investigational octreotide (CAM2029) extended-release injection for acromegaly ... Prevalence of ...